UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 5, 2019 (December 2, 2019)
LONGEVITY ACQUISITION CORPORATION
(Exact name of registrant as specified in its charter)
| British Virgin Islands | 001-38637 | N/A |
(State or other jurisdiction
of incorporation) | (Commission
File Number) | (IRS Employer
Identification No.) |
Yongda International Tower No. 2277
Longyang Road, Pudong District, Shanghai
People’s Republic of China
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (86) 21-60832028
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
| Ordinary shares, no par value | | LOAC | | The NASDAQ Stock Market LLC |
| Warrants to purchase one-half of one ordinary share | | LOACW | | The NASDAQ Stock Market LLC |
| Rights to receive one-tenth (1/10) of one ordinary share | | LOACR | | The NASDAQ Stock Market LLC |
| Units, each consisting of one ordinary share, one right and one warrant | | LOACU | | The NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On December 2, 2019, Minguang Wang resigned as a Class I director of Longevity Acquisition Corporation (the “Company”) to pursue other professional interests.
On December 2, 2019, the board of directors (the “Board”) of the Company appointed Pai Liu as a Class I director to serve until the 2019 annual meeting of stockholders of the Company. Mr. Liu has also been appointed to serve as a member of the audit committee of the Board and as the chairman of the compensation committee of the Board.
Pai Liu has served as chief executive officer of Wuhan Dacheng Equity Investment Fund Management Company since July 2016. From December 2014 to April 2016, Mr. Liu was a senior associate of Deloitte in China. From September 2013 to October 2014, Mr. Liu served as a senior associate of Mazars Group in China. From October 2011 to September 2013, Mr. Liu served as an associate of PricewaterhouseCoopers in its Shanghai office and was involved in the auditing of large and medium-sized foreign enterprises. Mr. Liu earned his Master’s degree in accounting & finance from Leeds University in the United Kingdom and received a bachelor’s degree in finance from the South Central University for Nationalities in China.
There were no arrangements or understandings between Mr. Liu and any other persons pursuant to which Mr. Liu was appointed as a director of the Company. In addition, there are no family relationships between Mr. Liu and any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer. Furthermore, since the inception of the Company, there have been no transactions in which the Company was or is to be a participant and the amount involved exceeds $120,000, and in which Mr. Liu had or will have a direct or indirect material interest, and there are currently no such proposed transactions.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | LONGEVITY ACQUISITION CORPORATION | |
| | | | |
| Date: December 5, 2019 | By: | /s/ Matthew Chen | |
| | | Name: Matthew Chen | |
| | | Title: Chairman and Chief Executive Officer | |
